
Christopher R. Stone
Examiner (ID: 15088, Phone: (571)270-3494 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1609, 1628, 4173, 1614 |
| Total Applications | 750 |
| Issued Applications | 250 |
| Pending Applications | 42 |
| Abandoned Applications | 457 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18244422
[patent_doc_number] => 20230076733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => Combination Therapy
[patent_app_type] => utility
[patent_app_number] => 17/791571
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/791571 | Combination Therapy | Jan 7, 2021 | Pending |
Array
(
[id] => 16930823
[patent_doc_number] => 20210196712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => METHODS OF TREATING COCHLEAR SYNAPTOPATHY
[patent_app_type] => utility
[patent_app_number] => 17/142742
[patent_app_country] => US
[patent_app_date] => 2021-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17142742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/142742 | METHODS OF TREATING COCHLEAR SYNAPTOPATHY | Jan 5, 2021 | Abandoned |
Array
(
[id] => 16898885
[patent_doc_number] => 20210177801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS
[patent_app_type] => utility
[patent_app_number] => 17/129678
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129678
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/129678 | UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS | Dec 20, 2020 | Abandoned |
Array
(
[id] => 20438622
[patent_doc_number] => 12509449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Anthelmintic compounds comprising a quinoline structure
[patent_app_type] => utility
[patent_app_number] => 17/785656
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49378
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785656
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/785656 | Anthelmintic compounds comprising a quinoline structure | Dec 16, 2020 | Issued |
Array
(
[id] => 17602830
[patent_doc_number] => 11331299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Medicinal use of serrulatane diterpenes
[patent_app_type] => utility
[patent_app_number] => 17/123539
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 23
[patent_no_of_words] => 49407
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17123539
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/123539 | Medicinal use of serrulatane diterpenes | Dec 15, 2020 | Issued |
Array
(
[id] => 17602830
[patent_doc_number] => 11331299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Medicinal use of serrulatane diterpenes
[patent_app_type] => utility
[patent_app_number] => 17/123539
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 23
[patent_no_of_words] => 49407
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17123539
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/123539 | Medicinal use of serrulatane diterpenes | Dec 15, 2020 | Issued |
Array
(
[id] => 16868851
[patent_doc_number] => 20210162318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => SYSTEM FOR FILTERING ORGANIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/122564
[patent_app_country] => US
[patent_app_date] => 2020-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17122564
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/122564 | System for filtering organic compounds | Dec 14, 2020 | Issued |
Array
(
[id] => 19550931
[patent_doc_number] => 12134627
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-05
[patent_title] => Boron hydroxyl-containing organic compound, method for preparing same and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/607409
[patent_app_country] => US
[patent_app_date] => 2020-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7547
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/607409 | Boron hydroxyl-containing organic compound, method for preparing same and use thereof | Dec 13, 2020 | Issued |
Array
(
[id] => 18222909
[patent_doc_number] => 20230061903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => ENHANCED PRODUCTION OF HUMIC ACIDS FROM COAL-LIGNITE VIA WATER-OXYGEN SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/783578
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783578
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/783578 | Enhanced production of humic acids from coal-lignite via water-oxygen systems | Dec 9, 2020 | Issued |
Array
(
[id] => 19584916
[patent_doc_number] => 20240382473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => Combination Therapies for Treatment of Myelodysplastic Syndrome
[patent_app_type] => utility
[patent_app_number] => 17/782033
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782033
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782033 | Combination Therapies for Treatment of Myelodysplastic Syndrome | Dec 3, 2020 | Abandoned |
Array
(
[id] => 16718522
[patent_doc_number] => 20210085669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => TREATING PATIENTS HARBORING AN ISOCITRATE DEHYDROGENASE 1 (IDH-1) MUTATION
[patent_app_type] => utility
[patent_app_number] => 17/112269
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112269
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112269 | Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation | Dec 3, 2020 | Issued |
Array
(
[id] => 18167976
[patent_doc_number] => 20230034584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => INHIBITORS OF SHP2
[patent_app_type] => utility
[patent_app_number] => 17/782360
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782360 | INHIBITORS OF SHP2 | Dec 2, 2020 | Abandoned |
Array
(
[id] => 18294204
[patent_doc_number] => 20230103890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Photooxygenation Catalyst Compound and Medicine Comprising Same
[patent_app_type] => utility
[patent_app_number] => 17/780720
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17780720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/780720 | Photooxygenation Catalyst Compound and Medicine Comprising Same | Dec 1, 2020 | Pending |
Array
(
[id] => 19411706
[patent_doc_number] => 12077511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Organic amine salt of key intermediate of Elagolix sodium and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 17/426522
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1001
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426522
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/426522 | Organic amine salt of key intermediate of Elagolix sodium and preparation method thereof | Nov 23, 2020 | Issued |
Array
(
[id] => 17170285
[patent_doc_number] => 20210323955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHODS AND AGENTS FOR TREATING DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/101753
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101753
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/101753 | Methods and agents for treating disease | Nov 22, 2020 | Issued |
Array
(
[id] => 17065723
[patent_doc_number] => 20210267938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/952401
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952401
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952401 | MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF | Nov 18, 2020 | Abandoned |
Array
(
[id] => 18147585
[patent_doc_number] => 20230021442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => PHENOTHIAZINE FERROPTOSIS INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/778831
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778831
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778831 | Phenothiazine ferroptosis inhibitor, preparation method therefor and application thereof | Nov 17, 2020 | Issued |
Array
(
[id] => 17571059
[patent_doc_number] => 11319317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => (Hetero)arylamide compound for inhibiting protein kinase activity
[patent_app_type] => utility
[patent_app_number] => 17/098675
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15562
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098675
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098675 | (Hetero)arylamide compound for inhibiting protein kinase activity | Nov 15, 2020 | Issued |
Array
(
[id] => 16838329
[patent_doc_number] => 20210146341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => SUPPORTED COPPER CATALYST AND SELECTIVE HYDROGENATION OF FURAN-BASED COMPOUNDS USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/096835
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/096835 | Supported copper catalyst and selective hydrogenation of furan-based compounds using the same | Nov 11, 2020 | Issued |
Array
(
[id] => 18207442
[patent_doc_number] => 20230053699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SUBSTITUTED-ISOXAZOLINE-CONTAINING AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/774814
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774814
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/774814 | Substituted-isoxazoline-containing aromatic compound, preparation method therefor, herbicidal composition and use thereof | Nov 3, 2020 | Issued |